233 related articles for article (PubMed ID: 21844812)
1. Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling.
Wang G; Beattie MS; Ponce NA; Phillips KA
Genet Med; 2011 Dec; 13(12):1045-50. PubMed ID: 21844812
[TBL] [Abstract][Full Text] [Related]
2. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
Hull LE; Haas JS; Simon SR
Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717
[TBL] [Abstract][Full Text] [Related]
3. Participation of Korean families at high risk for hereditary breast and ovarian cancer in BRCA1/2 genetic testing.
Sun Y; Kang E; Baek H; Jung J; Hwang E; Koo J; Kim EK; Kim SW
Jpn J Clin Oncol; 2015 Jun; 45(6):527-32. PubMed ID: 25838294
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Bellcross CA; Leadbetter S; Alford SH; Peipins LA
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):728-35. PubMed ID: 23371291
[TBL] [Abstract][Full Text] [Related]
5. BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.
Chun DS; Berse B; Venne VL; DuVall SL; Filipski KK; Kelley MJ; Meyer LJ; Icardi MS; Lynch JA
Fam Cancer; 2017 Jan; 16(1):41-49. PubMed ID: 27589855
[TBL] [Abstract][Full Text] [Related]
6. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
7. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Kemp Z; Turnbull A; Yost S; Seal S; Mahamdallie S; Poyastro-Pearson E; Warren-Perry M; Eccleston A; Tan MM; Teo SH; Turner N; Strydom A; George A; Rahman N
JAMA Netw Open; 2019 May; 2(5):e194428. PubMed ID: 31125106
[TBL] [Abstract][Full Text] [Related]
9. Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery.
Kuerer HM; Hwang ES; Anthony JP; Dudley RA; Crawford B; Aubry WM; Esserman LJ
Ann Surg Oncol; 2000 Jun; 7(5):325-32. PubMed ID: 10864338
[TBL] [Abstract][Full Text] [Related]
10. Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey.
Demir S; Tozkir H; Gurkan H; Atli EI; Yalcintepe S; Atli E; Sezer YA; Eker D; Tuncbilek N; Tastekin E; Ozen Y; Cicin I
J BUON; 2020; 25(3):1337-1347. PubMed ID: 32862574
[TBL] [Abstract][Full Text] [Related]
11. Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.
Moreno L; Linossi C; Esteban I; Gadea N; Carrasco E; Bonache S; Gutiérrez-Enríquez S; Cruz C; Díez O; Balmaña J
Clin Transl Oncol; 2016 Oct; 18(10):981-7. PubMed ID: 26742938
[TBL] [Abstract][Full Text] [Related]
12. Trends in BRCA Test Utilization in an Integrated Health System, 2005-2015.
Knerr S; Bowles EJA; Leppig KA; Buist DSM; Gao H; Wernli KJ
J Natl Cancer Inst; 2019 Aug; 111(8):795-802. PubMed ID: 30753636
[TBL] [Abstract][Full Text] [Related]
13. Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.
Hayden S; Mange S; Duquette D; Petrucelli N; Raymond VM;
J Genet Couns; 2017 Aug; 26(4):859-865. PubMed ID: 28093663
[TBL] [Abstract][Full Text] [Related]
14. Willingness of Japanese patients with breast cancer to have genetic testing of BRCA without burden of expenses.
Nakagomi H; Sakamoto I; Hirotsu Y; Amemiya K; Mochizuki H; Inoue M; Nakagomi S; Kubota T; Omata M
Breast Cancer; 2016 Jul; 23(4):649-53. PubMed ID: 26025266
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
Cragun D; Bonner D; Kim J; Akbari MR; Narod SA; Gomez-Fuego A; Garcia JD; Vadaparampil ST; Pal T
Breast Cancer Res Treat; 2015 May; 151(1):169-76. PubMed ID: 25868867
[TBL] [Abstract][Full Text] [Related]
16. BRCA1/2 Testing in Massachusetts Among Women With Private Insurance or Medicaid, 2011-2015.
Pace LE; Baum CF; Horvath K; Raja SC; Cohen J; Hawkins SS
Med Care; 2020 Nov; 58(11):963-967. PubMed ID: 32925457
[TBL] [Abstract][Full Text] [Related]
17. BRCA testing in unaffected young women in the United States, 2006-2017.
Guo F; Scholl M; Fuchs EL; Berenson AB; Kuo YF
Cancer; 2020 Jan; 126(2):337-343. PubMed ID: 31568561
[TBL] [Abstract][Full Text] [Related]
18. The first Japanese nationwide multicenter study of
Enomoto T; Aoki D; Hattori K; Jinushi M; Kigawa J; Takeshima N; Tsuda H; Watanabe Y; Yoshihara K; Sugiyama T
Int J Gynecol Cancer; 2019 Jul; 29(6):1043-1049. PubMed ID: 31263023
[TBL] [Abstract][Full Text] [Related]
19. Trends in coverage and reimbursement for reproductive genetic counseling in New Jersey by multiple payers from 2010 to 2018.
Spinosi F; Khan S; Seymour C; Ashkinadze E
J Genet Couns; 2021 Dec; 30(6):1748-1756. PubMed ID: 34223664
[TBL] [Abstract][Full Text] [Related]
20. Genetic Testing After Previous BRCA Testing: A Case Study.
Ward M
Clin J Oncol Nurs; 2016 Dec; 20(6):660-663. PubMed ID: 27857264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
